The Recall Desk

FDA (Drugs) recall action 83074

RXQ Compounding LLC recalled 86 products on 2019-08-14

The FDA (Drugs) publishes a recall like this one as 86 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 86 pages.

Products
86
Announced
2019-08-14
Critical
0
Units
—

Why these products were recalled

Lack of Assurance of Sterility

Crystallization

The agency’s own wording, quoted from the enforcement report.

26–50 of 86

  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Cyanocobalamin Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Cyanocobalamin 1200mcg/mL MDV Injection due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0946-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Mitomycin Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Mitomycin 0.04% ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0917-01
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Turbo Drops Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Turbo Drops ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0205-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls MIC B12 W/B6 Due to Sterility Concerns

    RXQ Compounding LLC is recalling MIC B12 W/B6 (Lipostat Plus) vials because the FDA identified a lack of assurance of sterility.

    Product
    MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0978-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Procaine HCL Injectable Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Procaine HCL 20 mg/mL Injectable Solution because the product lacks assurance of sterility.

    Product
    PROCAINE HCL 20 MG/ML (MDV) INJECTABLE SOLUTION, 30 ML per vial. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0987-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Methylcobalamin Injectable Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Methylcobalamin 10mg/ml Injectable Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    METHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0130-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Avastin Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Avastin 25mg/mL syringes because the company cannot ensure the product is sterile. The recall covers all lots within their expiration dates.

    Product
    Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Calcium Chloride Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Calcium Chloride 100mg/mL Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    CALCIUM CHLORIDE 100MG/ML (PFV) INJ SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0920-10
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Ascorbic Acid Injection Due to Crystallization

    RXQ Compounding LLC is recalling Ascorbic Acid 400 MG/ML Injection Solution because of crystallization. The recall covers all lots within expiry distributed nationwide.

    Product
    Ascorbic Acid 400 MG/ML (Non-Corn) Injection Solution, 65 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0914-65
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Pyridoxine Vials Due to Sterility Concerns

    RXQ Compounding LLC is recalling Pyridoxine (MDV) 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Lidocaine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Lidocaine 0.75%/Epinephrine 0.025% syringes because the FDA determined there is a lack of assurance of sterility.

    Product
    LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0919-01
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Midazolam Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Midazolam 1mg/mL injection syringes because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls EDETATE DISODIUM 30% INJECTABLE Due to Sterility Concerns

    RXQ Compounding LLC is recalling EDETATE DISODIUM 30% INJECTABLE, 100 ML vials, because the product lacks assurance of sterility.

    Product
    EDETATE DISODIUM 30% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0931-11
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Glutathione Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Glutathione 200mg/ml Injection Solution because the product lacks assurance of sterility. All lots within expiry are affected nationwide.

    Product
    GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0971-81
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls TURBO DROPS Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling TURBO DROPS ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    TURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0206-05
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Niacinamide Vials Due to Sterility Concerns

    RXQ Compounding LLC is recalling Niacinamide 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0938-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydroxocobalamin 1000 mcg/mL injections because the product lacks assurance of sterility.

    Product
    HYDROXOCOBALAMIN 1000 MCG/ML (MDV), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0926-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls EDETATE CALCIUM DISODIUM INJECTABLE Due to Sterility Concerns

    RXQ Compounding LLC is recalling EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE vials because the product lacks assurance of sterility.

    Product
    EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0934-11
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Dextrose 50% Injection Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dextrose 50% Injection Solution syringes because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Buffered Lidocaine HCL 1% Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Buffered Lidocaine HCL 1% Injection Solution because the product lacks assurance of sterility.

    Product
    BUFFERED LIDOCAINE HCL 1% INJECTION SOL (PF) SYR, 0.5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0139-84
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Lidocaine HCL 2% Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Lidocaine HCL 2% Injection Solution because the product lacks assurance of sterility. The recall covers all lots within their expiry dates.

    Product
    LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0172-20
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Thiamine HCL Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Thiamine HCL 100mg/mL Injection because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    THIAMINE HCL 100MG/ML (MDV) INJECTION, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0950-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Dextrose 50% Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dextrose 50% Injection Solution vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    DEXTROSE 50% INJECTION SOLUTION (PF) VIAL, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Manganese Sulfate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Manganese Sulfate Monohydrate Injection because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0952-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Potassium Chloride Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Potassium Chloride 15% Injection Solution due to a lack of assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    POTASSIUM CHLORIDE 15% (2MEQ/ML) INJ SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0954-30
    Category
    Distribution
    0 states